Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.MaaT Pharma doses first patient in phase 2 trial of biotherapeutic to treat acute GvHD
Image: MaaT Pharma has enrolled first patient in phase 2 clinical trial of first-in-class biotherapeutic. Photo: courtesy of Drew Hays / Unsplash.
Image: MaaT Pharma has enrolled first patient in phase 2 clinical trial of first-in-class biotherapeutic. Photo: courtesy of Drew Hays / Unsplash.